Ebk (EB-canq) is a new research chemicals that acts like bk-ebdp, the chemical structure will release later!
Ebk (EB-canq) is for research test purpose only, for more information please refer to bkebdp!
EB BK-EB CRYSTAL
Good for research
(BK-EBDP is a stimulant compound . Research result shows that Ephylone has similar effects as to ethylone. So this product is intended for forensic applications,and not intended for human or animal consumption .BK-EBDP ephylone is a legal designer chemical or research chemical, We are legit chemicals vendor and suppliers providing research chemicals for 4 years. by purchasing at our online shop site you will get a safe and easy shopping experience , and this is where to buy best and cheap china research chemical, the usa europe uk nederland canada research chemical sources. please feel free buy bk-ebdp ephylone from us.
BK-EBDP (ephylone) research chemical properties
CAS: 8492312-32-2
Formula: C14H19NO3
Molecular weight: 249.310
Compound purity: > 99.7%
Appearance: Crystals
Synonyms: bkedbp, Ephylone, BK-Ethyl-K, BK-EBDP
More information about BK-EBDP (ephylone)
Ephylone passes the formal and systematic IUPAC name (benzo[d][1,3]dioxo1-5-y1)-2-(ethylamino)pentan-1-one, posseses an empirical molecular formula C14H19NO3 plus a molar mass of 250 grams. Ephylone which passes what they’re known as BK-Ethyl-K and BK-EBDP can be a chemical within the class substituted cathinones.
It is associated with a wave of substituted cathinones which have emerged lately that there are little info on individuals to drink. Ephylone could be the N-methyl analogue in the cathinone pentylone. EBK (EB-CANQ) for sale online
N-Ethylpentylone (also known as bk-EBDP, βk-EBDP, and ephylone) is a novel stimulant–entactogen substance of the cathinone class. Ephylone is chemically related to pentylone and belongs to a group of compounds known as the substituted cathinones. Little is known about its pharmacology, although it likely produces its effects by increasing levels of serotonin, dopamine, and norepinephrine in the brain.
Ephylone was developed in the 1960s by Boehringer Ingelheim as a central nervous system stimulant, although it never became marketed. Reports of recreational use first appeared in late 2015. Since then, its prevalence has steadily risen, particularly at dance music festivals where it appears as an adulterant or counterfeit for MDMA.Ephylone has been linked to numerous hospitalizations and overdose deaths.
